Navigation Links
For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms
Date:4/27/2009

Lamictal Will Retain Decision Resources' Clinical Gold Standard Status for Bipolar Depression, According to a New Report from Decision Resources

WALTHAM, Mass., April 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed psychiatrists identify a therapy's effect on decrease in severity of depressive symptoms as the attribute that most influences their prescribing decisions in bipolar depression. Clinical data and the opinions of interviewed thought leaders indicate that current and emerging therapies have no advantage in this attribute over AstraZeneca's Seroquel, the sales-leading agent in the market.

The new report entitled Bipolar Depression: Despite Negative Results, Physicians Still Hopeful About Aripiprazole also finds that an oral therapy that carries a lower risk of weight gain than Seroquel would earn a 21 percent patient share in bipolar depression in the United States and a 30 percent patient share in Europe, according to surveyed U.S. and European psychiatrists. The report also finds that, despite the failure of Bristol-Myers Squibb/Otsuka Pharmaceutical's Abilify (aripiprazole) in bipolar depression clinical trials, most interviewed thought leaders believe that Abilify is still an efficacious therapy for bipolar depression.

In 2008, Decision Resources' proprietary clinical gold standard for bipolar depression was lamotrigine (GlaxoSmithKline's Lamictal, generics). Based on available data and expert opinion, lamotrigine will retain gold standard status through 2017. While some therapies in development for bipolar depression hold promise, most have efficacy, safety and tolerability, and/or delivery features that are inferior when compared with lamotrigine.

"Owing to its efficacy and tolerability advantages, lamotrigine edged out Seroquel, its closest competitor, to become
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New National Online Survey Says Bipolar Depressive Symptoms Have Impact on Day-To-Day Tasks as Well as Social Activities(1)
2. Repligen Licenses Patent Rights for Treatment of Bipolar Disorder
3. National Audience of Psychiatrists Assembling in Chicago for Conference on Bipolar Disorder and ADHD
4. HealthyPlace.com, the Largest Consumer Mental Health Site, Launches Mediminder, a Free Medication Reminder Tool for the More Than 30 Million People Who Suffer From Depression, Anxiety, Bipolar Disorder and Other Mental Health Conditions
5. Kids Risks Increase When Parents Are Bipolar
6. HealthyPlace.com, the Largest Consumer Mental Health Site, Re-Launches With Important New Features for the More Than 30 Million People Who Suffer from Anxiety, Depression and Bipolar Disorder
7. AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
8. Common Genes Link Bipolar Disorder, Schizophrenia
9. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
10. Repligen Initiates Phase 2b Clinical Trial of RG2417 in Bipolar Disorder
11. Children of Older Fathers at Risk for Bipolar Disorder

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., BEDFORD, Mass., Nov. 27 /PRNewswire-FirstCall/...ny"), a supplier of precision technology products ... annual meeting of the Company,s shareholders has ...me and location of the meeting will be announced i...y received a requisition notice from Stephen Bersh...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 ...ed that Blair Lambert, CFO/COO, will present at th...held at the May Fair Hotel in London, England, on ..., To listen to a live broadcast of The Gymboree ...se log on to www.gymboree.com, click on "Our Compa...
(Date:11/27/2009)... XenaCare Holdings has announced t...tis Foundation, one of the largest nonprofit organ...c health education. , Del...e Holdings, Inc. (OTCBB: XCHO), a company speciali...onsumer healthcare products, has announced today t...
(Date:11/27/2009)... Voyant Health™ announced to...has licensed its TraumaCad Enterprise orthopedic t...ow solution. , (PRWEB) No...today that Spectrum Health (Grand Rapids, Michigan... templating solution and its TraumaCad Extend work...
(Date:11/26/2009)..., NEW YORK, Nov. 27 With cold and... to employ good practices to control the spread of...e proactive not only to keep ourselves healthy, bu...id Eileen Finerty, RN, MS, CIC (certified in infec...rol and occupational health at Hospital for Specia...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
...tes 130,000 Jobs and $13.5 Billion in Economic Act... health plans are an essential and vital part of t...3.5 billion in economic activity, according to a...ide consulting firm with expertise in health care ...
...ctos tied to a retinal disorder, study finds , ...s of diabetes drugs called glitazones are associat...complication called diabetic macular edema (DME), ...azone (Actos) and rosiglitazone (Avandia). , The U...
...for valuing the opinions of African American emplo...ent to diversity at Sodexo, a leading integrated f...llows me to be open about who I am as an African A...ervices and chair of the African American Leadersh...
...Missouri, April 7 , - Acquisition Extends the... Elsevier, the leading global publisher of scient...nd services, announced today the acquisition of,th...rated into Elsevier,s Evolve Testing and Remediati...
...eumatology Thought Leader Panel Creates a ,Fantasy... 7 MedPredict Market Research, a global provider ...ket research, has published a new report providing...atic arthritis. , , To develop this analysis, ent...
...L, April 7, 2009) Managing pain in the ICU is an ... care team. However, new reports suggest that taki... be the key to managing pain in the ICU and even d...hysicians (ACCP), the two reports titled, Evaluati...
Other Medicine News:Health News:California Health Plans Vital to State's Economy 2Health News:Certain Diabetes Drugs May Pose Eye Risk 2Health News:Sodexo Named as One of the Top Three Companies for African Americans on 2009 DiversityInc Top Ten Companies List 2Health News:Elsevier Acquires Professional Development Software, Inc., Provider of 'Software for Nurses' Online Learning Education 2Health News:New Report Defines Challenges for New Entrants in Key Rheumatology Markets 2Health News:'Pain in the ICU' report suggests comprehensive approach 2Health News:'Pain in the ICU' report suggests comprehensive approach 3
(Date:11/25/2009)... STAFA, Switzerland, Nov. 25 From...of innovative hearing solutions, presented the sec...nce, focusing on the special needs of the older po...experts in aging and audiology from around the wor...with older people with hearing loss for an opportu...
(Date:11/25/2009)...ARK, Md., Nov. 25 Remed...ing cream-like foam that stops severe bleeding, wo...curity Idea category of the Global Security Challe...Selected from more than 100 entries from around th...t the GSC Security Summit conference held at the L...
(Date:11/25/2009)...ORK, Nov. 25 Reportlinker.com anno...le in its catalogue: ,, United States Dental D..., http://www.reportlinker.com/p0158733/United-Sta...o-2015.html ,, United States Dental Devices Ma... ,, This report is an essential source for in-...
Breaking Medicine Technology:Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13Sequella Obtains Funding to Continue Expansion of its Anti infectives Pipeline 14432 1Sequella Obtains Funding to Continue Expansion of its Anti infectives Pipeline 14432 2Sequella Obtains Funding to Continue Expansion of its Anti infectives Pipeline 14432 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 1National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 2National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 3National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 4National Institutes of Health Awards More Than 2454 Million to Kaiser Permanente to Conduct Health Research 5390 5Stereotaxis Announces Underwriters Exercise of Over Allotment Option 5386 1Stereotaxis Announces Underwriters Exercise of Over Allotment Option 5386 2Stereotaxis Announces Underwriters Exercise of Over Allotment Option 5386 3
...HASE 3 CLINICAL TRIAL FOR NATURLOSE(R) ANTICIPATED...orporated (Nasdaq: SPEX ), an innovator in biote...y consulting services to food, supplement, biotech...ed the postponement of its 2009 Annual Shareholder...ing will instead be held during the Fall of 2009, ...
... 11 Premier Research Group Limited, the internati...ce that it has expanded their medical device opera...s. Their dedicated medical device group has been o...997 and is considered an industry leader for manag... , "Our clients have requested expanded medical d...
Other Medicine Technology:Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data 2Spherix Postpones 2009 Annual Shareholders Meeting to Share Interim Diabetes Clinical Trial Data 3Premier Research Expands its Medical Device Operations to the United States 2
HbA1c/Hb Calibrator Series
STA HEPANORM H
STA HEPARIN CONTROL
STA COAG CONTROL N + ABN
Medicine Products: